Metoprolol 25 mg tablet picture
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol 25 mg Tablet: Visual Identification and Clinical Insights
Visual Identification of Metoprolol 25 mg Tablet
Metoprolol, a selective beta1-adrenoreceptor antagonist, is commonly prescribed for managing hypertension and other cardiovascular conditions. The 25 mg tablet of metoprolol is typically small, round, and film-coated. The appearance can vary slightly depending on the manufacturer, but it generally has a scored line to facilitate splitting the dose if necessary. The tablet is often white or off-white in color.
Bioavailability and Pharmacokinetics of Metoprolol
Combination with Hydrochlorothiazide
Research has shown that when metoprolol is combined with hydrochlorothiazide (HCT) in a single tablet, there is no significant impact on the bioavailability or pharmacokinetics of either drug. This means that the presence of HCT does not alter the absorption or effectiveness of metoprolol, and vice versa. The average half-life of metoprolol remains consistent at approximately 4.4 hours, which is similar to when it is administered alone.
Sustained-Release Formulations
The development of sustained-release formulations of metoprolol, such as metoprolol succinate, has been a significant advancement. These formulations allow for a more controlled release of the drug, providing a stable plasma concentration over a longer period. This can be particularly beneficial for patients who require consistent blood pressure control throughout the day. The sustained-release form has been shown to significantly reduce the morning blood pressure peak and increase heart rate variability compared to conventional metoprolol tartrate tablets.
Clinical Efficacy and Safety
Comparison of Formulations
Clinical studies comparing different formulations of metoprolol have demonstrated that both conventional and sustained-release forms are effective in reducing systolic and diastolic blood pressure in patients with mild hypertension. However, the sustained-release form offers additional benefits, such as reducing the incidence of morning blood pressure peaks and improving heart rate variability. Both formulations have been found to be safe, with no significant differences in liver and kidney function, blood lipids, or glucose levels between the two groups.
Manufacturing and Quality Control
The manufacturing process for metoprolol tablets, particularly the sustained-release bi-layer tablets, has been optimized to ensure consistent quality and efficacy. The process involves precise control of mixing, drying, and coating parameters to produce a stable and reproducible product. This ensures that each tablet meets the required specifications and provides the intended therapeutic effect.
Conclusion
Metoprolol 25 mg tablets are a crucial medication for managing hypertension and other cardiovascular conditions. The tablets are typically small, round, and film-coated, with a consistent appearance across different manufacturers. Research indicates that both conventional and sustained-release formulations are effective and safe, with the latter offering additional benefits in blood pressure control and heart rate variability. The optimized manufacturing process ensures that these tablets are of high quality and efficacy, providing reliable treatment for patients.
Sources and full results
Most relevant research papers on this topic